OS Therapies shareholders approve amended 2023 incentive compensation plan at annual meeting
OSTX•Shareholders approve amended incentive plan and elect directors
- OS Therapies held its annual shareholder meeting on Sept. 9, 2026.
- Shareholders approved an amended and restated 2023 Incentive Compensation Plan, adopting the updated plan terms.
- Voters also elected six directors to serve until the 2027 annual meeting.
- MaloneBailey was ratified as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
